This hypericin-PDT mediated CASP8 activation has been reported in both Jurkat T-lymphocytes [87] and nasopharyngeal carcinoma cells [81], but not in a variety of murine and human cancer cell lines [84], [85], [88], [89]. The gene discussed is CASP8; the disease is nasopharyngeal carcinoma.